Ha Tay Pharmaceutical JSC (HNX:DHT)
Vietnam · Delayed Price · Currency is VND 69,500
-500 (-0.71%)
At close: Feb 2, 2026
Ha Tay Pharmaceutical JSC Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 |
Net Income | 66,570 | 71,772 | 85,056 | 95,211 | 67,946 | 92,047 |
Depreciation & Amortization | 21,282 | 20,481 | 17,078 | 17,448 | 16,435 | 13,259 |
Other Amortization | - | - | - | - | 216.67 | - |
Loss (Gain) From Sale of Assets | -20,273 | -14,478 | -4,608 | -9,923 | - | -396.34 |
Other Operating Activities | 717.96 | 5,087 | -1,352 | 2,653 | -14,450 | -491.67 |
Change in Accounts Receivable | 22,421 | 28,972 | 147,484 | -159,477 | 51,385 | -65,800 |
Change in Inventory | -186,118 | -149,027 | 81,720 | -120,922 | 33,804 | -29,833 |
Change in Accounts Payable | 152,434 | 67,274 | -55,823 | 133,037 | -182,898 | 93,929 |
Change in Other Net Operating Assets | -1,893 | -2,121 | 1,245 | 2,502 | 4,269 | -8,022 |
Operating Cash Flow | 55,141 | 27,959 | 270,799 | -39,471 | -23,293 | 94,692 |
Operating Cash Flow Growth | -78.32% | -89.68% | - | - | - | -11.63% |
Capital Expenditures | -2,903 | -143,132 | -366,523 | -246,553 | -60,524 | -89,016 |
Sale of Property, Plant & Equipment | 113.64 | 150 | 281 | 86.82 | 244.42 | 1,126 |
Investment in Securities | 8,000 | - | - | - | -350,000 | - |
Other Investing Activities | 7,981 | 7,215 | 3,627 | 26,265 | 106.17 | 1,299 |
Investing Cash Flow | -16,808 | -125,767 | -409,615 | 76,799 | -410,174 | -86,591 |
Long-Term Debt Issued | - | 746,915 | 782,402 | 774,504 | 741,472 | 487,721 |
Long-Term Debt Repaid | - | -780,429 | -615,546 | -727,089 | -656,225 | -445,691 |
Net Debt Issued (Repaid) | -41,370 | -33,513 | 166,857 | 47,414 | 85,247 | 42,030 |
Issuance of Common Stock | - | - | 180,600 | - | 367,749 | - |
Common Dividends Paid | -39,023 | -80,194 | - | -51,288 | -20,359 | -44,382 |
Financing Cash Flow | -80,393 | -113,707 | 347,457 | -3,873 | 432,637 | -2,352 |
Foreign Exchange Rate Adjustments | -5.46 | -5.46 | 17.77 | 8.57 | 4.8 | 3.48 |
Net Cash Flow | -42,066 | -211,521 | 208,658 | 33,463 | -825.13 | 5,752 |
Free Cash Flow | 52,238 | -115,173 | -95,725 | -286,024 | -83,817 | 5,676 |
Free Cash Flow Growth | - | - | - | - | - | -91.51% |
Free Cash Flow Margin | 2.32% | -5.52% | -4.79% | -15.57% | -5.21% | 0.28% |
Free Cash Flow Per Share | 576.74 | -1271.59 | -1720.88 | - | -1038.49 | 69.79 |
Cash Interest Paid | 15,161 | 13,417 | 20,100 | 14,350 | 13,953 | 13,369 |
Cash Income Tax Paid | 19,778 | 18,894 | 26,106 | 21,049 | 16,423 | 24,547 |
Levered Free Cash Flow | - | -68,973 | -128,082 | -315,152 | -114,140 | 13,540 |
Unlevered Free Cash Flow | - | -60,567 | -115,520 | -306,212 | -105,394 | 21,867 |
Change in Working Capital | -13,156 | -54,902 | 174,625 | -144,860 | -93,440 | -9,727 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.